Matteo Cameli

2 works

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy

1. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

   Krzysztof J. Filipiak‬, Miguel Camafort, Matteo Cameli +9

   ArticleLipoproteins and Cardiovascular HealthCardiology Journal20220 citations

   ABIABI:AkademIndex/openalex/2022.article.001294

2. EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024

   Krzysztof J. Filipiak‬, Matteo Cameli, Santiago J. Freire +9

   Review articleBlood Pressure and Hypertension StudiesCardiology Journal20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000204